InfyCalculator
❤️

Padua Prediction Score Calculator (VTE in Medical Patients)

Venous thromboembolism risk for hospitalised medical patients with the Padua Prediction Score — active cancer, prior VTE, reduced mobility, thrombophilia, trauma, age, heart or respiratory failure, MI or stroke, infection, obesity, hormones.

Active cancer — metastases and/or chemo or radiotherapy in the last 6 months (3)
Previous VTE, excluding superficial thrombophlebitis (3)
Reduced mobility — bed rest with bathroom privileges ≥ 3 days (3)
Known thrombophilic condition (3)
Recent trauma and/or surgery ≤ 1 month (2)
Age ≥ 70 (1)
Heart and/or respiratory failure (1)
Acute MI or ischaemic stroke (1)
Acute infection and/or rheumatological disorder (1)
Obesity, BMI ≥ 30 (1)
Ongoing hormonal treatment (1)
Loading calculator…

How it works

Active cancer 3 + prior VTE 3 + reduced mobility 3 + thrombophilia 3 + trauma/surgery 2 + age ≥ 70 1 + heart/respiratory failure 1 + MI/stroke 1 + infection/rheumatological 1 + obesity 1 + hormones 1; ≥ 4 = high risk

Medical inpatients — those admitted with pneumonia, heart failure, sepsis or stroke rather than for surgery — account for most hospital-acquired venous thromboembolism, yet many are over- or under-treated. The Padua Prediction Score, derived in Italy and endorsed by the ACCP guidelines, splits them cleanly: below 4 the VTE rate is well under 1% and anticoagulant prophylaxis offers little; at 4 or more the rate approaches 11% and prophylaxis cuts it roughly fivefold. The four heaviest items — active cancer, prior VTE, immobility and thrombophilia — each score three, so any one of them plus a single minor factor reaches the threshold. Pair it with a bleeding-risk assessment (IMPROVE) before prescribing.

Worked example

A 74-year-old admitted with pneumonia and confined to bed for four days: mobility 3 + age 1 + infection 1 = 5 — high risk, LMWH prophylaxis.

Frequently asked questions

What about the IMPROVE score?

IMPROVE VTE is an alternative with seven items; IMPROVE Bleed assesses bleeding risk. Many hospitals pair Padua (or IMPROVE VTE) with IMPROVE Bleed.

Does prophylaxis continue after discharge?

Routine extended prophylaxis is not recommended for medical patients; trials of extended DOAC prophylaxis showed modest benefit offset by bleeding, so it is reserved for selected high-risk patients.

Related calculators

Clinical decision tool for education and for use by trained clinicians alongside judgement — not a diagnosis and not a substitute for medical assessment. Scores validated in specific populations may not apply to every patient.